Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Rahmani, Farzaneha | Ghezzi, Laurab | Tosti, Valeriab | Liu, Jingxiaa; c | Song, Sheng-Kweid; e | Wu, Anthony T.d; e | Rajamanickam, Jayashreea | Obert, Kathleen A.b | Benzinger, Tammie L.S.a; g | Mittendorfer, Bettinah | Piccio, Laurab; e; f; i; 1 | Raji, Cyrus A.a; g; 1; *
Affiliations: [a] Mallinckrodt Institute of Radiology, Division of Neuroradiology, Washington University in St. Louis, St. Louis, MO, USA | [b] Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA | [c] Department of Surgery, Division of Public Health Sciences, Washington University in St. Louis, St. Louis, MO, USA | [d] Department of Physics, Washington University in St. Louis, St. Louis, MO, USA | [e] Hope Center for Neurological Disorders, Washington University in St. Louis, St. Louis, MO, USA | [f] Brain and Mind Centre, School of Medical Sciences, The University of Sydney, NSW, Australia | [g] Charles F. and Joanne Knight Alzheimer Disease Research Center, Washington University in St Louis, St. Louis, MO, USA | [h] Department of Medicine, Division of Geriatrics and Nutritional Science, Washington University in St. Louis, St. Louis, MO, USA | [i] Charles Perkin Centre, The University of Sydney NSW, Australia
Correspondence: [*] Correspondence to: Cyrus A. Raji, MD, PhD, Assistant Professor of Radiology and Neurology, Director, Neuromagnetic Resonance Imaging, Co-Director, Imaging, Knight Alzheimer Disease Research Center (ADRC), Washington University School of Medicine, Mallinckrodt Institute of Radiology, 4525 Scott Ave., Campus Box 8131, St. Louis, MO 63110, USA. Tel.: +1 314 273 0334; E-mail: craji@wustl.edu.
Note: [1] These co-authors contributed equal senior authorship to this work.
Abstract: Background:Multiple sclerosis (MS) is a prototype neuroinflammatory disorder with increasingly recognized role for neurodegeneration. Most first-line treatments cannot prevent the progression of neurodegeneration and the resultant disability. Interventions can improve symptoms of MS and might provide insights into the underlying pathology. Objective:To investigate the effect of intermittent caloric restriction on neuroimaging markers of MS. Methods:We randomized ten participants with relapsing remitting MS to either a 12-week intermittent calorie restriction (iCR) diet (n = 5) or control (n = 5). Cortical thickness and volumes were measured through FreeSurfer, cortical perfusion was measured by arterial spin labeling and neuroinflammation through diffusion basis spectrum imaging. Results:After 12 weeks of iCR, brain volume increased in the left superior and inferior parietal gyri (p: 0.050 and 0.049, respectively) and the banks of the superior temporal sulcus (p: 0.01). Similarly in the iCR group, cortical thickness improved in the bilateral medial orbitofrontal gyri (p: 0.04 and 0.05 in right and left, respectively), the left superior temporal gyrus (p: 0.03), and the frontal pole (p: 0.008) among others. Cerebral perfusion decreased in the bilateral fusiform gyri (p: 0.047 and 0.02 in right and left, respectively) and increased in the bilateral deep anterior white matter (p: 0.03 and 0.013 in right and left, respectively). Neuroinflammation, demonstrated through hindered and restricted water fractions (HF and RF), decreased in the left optic tract (HF p: 0.02), and the right extreme capsule (RF p: 0.007 and HF p: 0.003). Conclusion:These pilot data suggest therapeutic effects of iCR in improving cortical volume and thickness and mitigating neuroinflammation in midlife adults with MS.
Keywords: Alzheimer’s disease, arterial spin labeling, caloric restriction, diffusion basis spectrum imaging, multiple sclerosis, neuroinflammation, prevention, relative cerebral blood flow
DOI: 10.3233/JAD-221007
Journal: Journal of Alzheimer's Disease, vol. 93, no. 1, pp. 263-273, 2023
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl